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A b s t r a c t  
Candida albicans is an Opportunistic human pathogen causes both superficial and life threatening 
mycoses fatal for immuno comprised patients. Many essential oils of spices possess antimycotic 
properties. The electrochemical gradient generated by PM-H+ATPase of C. albicans drives nutrient 
transport. H+ ATPase is associated with yeast to hyphal transition, later form being more pathogenic. 
It is thus important to identify spice extracts which apart from having low MIC also have a profound 
effect on H+ ATPase. With this in view we have investigated Eugenol alone and along with nutrients 
(xylose and glucose) on H+ ATPase functioning through H+ extrusion measurement. The antifungal 
activity of Eugenol alone and along with nutrients (xylose and glucose)was investigated by studying 
their effect on PM-ATPase mediated H+-Extrusion activity (H+ efflux) and growth of C. albicans (Disc 
diffusion and MIC).Eugenol inhibited the H+ ATPase as observed by H+ efflux monitored for 30 min. 
The oil has clear inhibitory effect on H+ efflux in the concentration range of 500µg/ml to 2000µg/ml. 
Eugenol has an inhibitory effect on growth and H+-Extrusion of H+ ATPase of C. albicans. Both 
glucose and xylose along with Eugenol have inhibitory effect on Candida growth but no such effect 
has been observed on H+-ATPase pump of the fungus. Eugenol has a potential to be exploited as 
future antifungal drug to target plasma membrane H+ ATPase of C. albicans and other pathogenic 
microbes.  
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Introduction 
The dimorphic yeast Candida albicans is an obligate associate of 
warm-blooded animals. It is frequently encountered as a harmless 
commensal of digestive system and vaginal tract and less 
frequently as an opportunistic pathogen. Mycelial form of Candida 
albicans is considered more invasive, difficult to phagocytose and 
therefore more pathogenic [1].  In addition to its dimorphism, C. 
albicans possess well-organized phenotypic switching system that 
probably helps the pathogen to evade the host immune defense 
[2].  
Patients that become severely immunocompromised because of 
underlying diseases such as leukemia, acquired 
immunodeficiency syndrome or patients who undergo cancer 
therapy, organ transplantation are particularly susceptible to 
opportunistic fungal infections [3]. A number of antifungal agents 
are available for the treatment of candidal infection [4] 
 
 
 
 
Recent studies have indicated C. albicans resitance to azoles or 
hepatotoxicity and nephrotoxicity linked to polyene use, 
particularly amphotericin B [5].  
The search for new molecular targets for antifungals has 
generated considerable research. Na, K-ATPase and H, K-
ATPase are well established molecular targets for several 
clinically important therapeutics [6; 7]. Fungal plasma membrane 
H+ ATPase has well defined properties that make it a highly 
desirable target. It plays a critical role in fungal physiology. It is 
essential for generating and maintaining an electrochemical 
gradient that is required for nutrient uptake. PM-ATPase is also 
associated with regulation of intracellular pH, dimorphism and 
pathogenicity of the fungus [8]. Several reports suggest H+ 
ATPase to be a desirable antifungal target [9-13]. 
 Spices and herbs have now long been recognized for their 
medicinal values. Essential oils have been used as home 
remedies for the treatment of vaginal candidiasis [14]. Eugenol, a 
phenolic compound is the main component of clove (Eugenia 
caryophillis) oil the compound are present in essential oils of 
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many plants and are proved to be active against many pathogenic 
bacteria, fungi and viruses [15]. There is a dearth of information 
on the effects of these bioactive compounds on C. albicans.  
Also there are no reports of using these compounds as inhibitory 
agents against PM-ATPase of C. albicans. Therefore, the present 
study was undertaken to evaluate the efficacy of eugenol as anti-
Candidal agent targeting its plasma membrane ATPase. 
Materials and Methods 
Candida albicans 10261 strain was collected from Enzyme 
Kinetics Lab, dept of Biosciences JMI New Delhi. Cells were 
grown in yeast extract, peptone and dextrose (1:2:2) medium. 
To prepare the yeast culture (YEPD) medium, yeast extracts 
peptones and dextrose are mixed in the ratio 1:2:2. For preparing 
solid agar medium (Nutrient agar 28g/L) was also added to the 
YEPD medium. YEPD Agar plate was streaked and streaking was 
done in the laminar flow to prevent dust and microbe 
contamination and incubated at 30°C for 24 hours.  It was 
covered with aluminum foil and was kept inverted in the fridge the 
culture was considered as stock culture. 
A loop full from the YEPD agar plate was introduced into 25 ml of 
autoclaved medium. This procedure was done in laminar flow. 
The medium was kept in incubated shaker at 150 r.p.m. till the 
culture reaches the stationary phase. 
Above prepared culture was considered as primary 
culture. 
Cells from primary culture was re-inoculated into a fresh YEPD 
medium and grown for 8-10 hrs i.e. up to mid log phase 
(secondary culture). The cells for experimental purpose were 
withdrawn in mid log phase.  Mid log phase cells harvested from 
YEPD medium were washed thrice with distilled water and 
routinely 100 mg cells were suspended in 5 ml solution containing 
0.1 M KCl and 0.1 mM CaCl2. 100 mg cells were taken with 0.1 M 
KCl and 0.1 CaCl2 mM and different concentration of Eugenol. 
The solution was adjusted to pH 7 and pH was monitored for 30-
minutes, recording noted after every one minute. 
Concentrations: 
Proton extrusion measurement with eugenol 
Group1:   contains cells only (control) 
Group2:    contains 500µg/ml eugenol 
Group3:    contains 625ml eugenol 
Group4:    contains 1 mg/ml eugenol 
Group5:    contains 2 mg/ml eugenol 
Proton extrusion measurement with eugenol & 
glucose 
Group1:   contains cells only (control) 
Group2:    contains 500µg/ml eugenol 
Group3:    contains 625ml eugenol 
Group4:    contains 1 mg/ml eugenol 
Group5:    contains 2 mg/ml eugenol 
Proton extrusion measurement with eugenol & 
xylose 
Group1:   contains cells only (control) 
Group2:    contains 500µg/ml eugenol 
Group3:    contains 625ml eugenol 
Group4:    contains 1 mg/ml eugenol 
Group5:    contains 2 mg/ml eugenol 
Results and Discussion 
       Natural plant products have been used since antiquity and 
their use is increasing nowadays. Some essential oils are known 
to have various health benefit properties. The antimicrobial and 
antifungal effect of plant essential oils has been described in 
several studies [5, 16, 17]  Antifungal [18], antibacterial [19], and 
antiparasitic properties of cinnamon have been repoted earlier. It 
has been found to be active against Candida albicans [20], 
Helicobacter pylori (the bacteria that causes stomach ulcers), 
and even head lice. Various studies have shown that oil extracted 
from cloves (Eugenol) is believed to account for their medicinal 
effects [21]. Preliminary human evidence confirms this effect in a 
clinical trial with AIDS patients suffering from oral Candida 
(thrush) infections that improved with topical application of 
cinnamon oil [20].  
Effect of Eugenol on H+ efflux of C. albicans 
        H+ efflux is a consequence of H+ ATPase activity and 
inhibition of enzyme activity correlates with cessation of cell 
growth. The effect of Eugenol on H+ ATPase activity was 
investigated by following H+ efflux as a function of time. Figure 1 
shows the inhibitory effect of different concentrations (500ug/ml to 
2000ug/ml) of Eugenol on H+ efflux by Candida albicans. Candida 
cells were present in 0.1 mM CaCl2 and 5mM KCl. As expected 
the untreated cells (control) showed acidification starting from pH 
7.0. The acidification decreased in the presence of Eugenol. The 
inhibition of H+ efflux increased with their increasing 
concentrations. A low concentration of 500ug/ml showed slightly 
less inhibition as compared to higher concentrations. All the other 
concentrations (625ug/ml, 1000ug/ml, and 2000ug/ml) showed a 
drastic decrease in efflux (Table1). For all concentrations, the pH 
showed a tendency towards alkalination. The above results show 
that Eugenol inhibit H+ efflux and hence H+ ATPase of C. 
albicans. 
Effect of Eugenol + glucose on H+ efflux of C. albicans 
Figure 2 shows the inhibitory effect of different concentrations 
(500ug/ml to 2000ug/ml) of Eugenol + glucose on H+ efflux by 
Candida albicans. For all concentrations, the pH showed a 
tendency towards alkalination. The above results show that 
Eugenol inhibits H+ efflux and hence H+ ATPase of C. albicans 
but glucose doesn’t show synergy with Eugenol (table2). 
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Effect of Eugenol + xylose on H+ efflux of C. albicans 
Figure 3 shows the inhibitory effect of different concentrations 
(500ug/ml to 2000ug/ml) of Eugenol + xylose on H+ efflux by 
Candida albicans. For all concentrations, the pH showed a 
tendency towards alkalination. The above results show that 
Eugenol inhibits H+ efflux and hence H+ ATPase of C. albicans 
but xylose doesn’t show synergy with Eugenol (Table3). 
The dimorphic yeast Candida albicans is an obligate associate of 
warm-blooded animals. It is frequently encountered as a harmless 
commensal of digestive system and vaginal tract and less 
frequently as an opportunistic pathogen. Mycelial form of Candida 
albicans is considered more invasive, difficult to phagocytose and 
therefore more pathogenic [1].  In addition to its dimorphism, C. 
albicans possess well-organized phenotypic switching system that 
probably helps the pathogen to evade the host immune defense 
[2].  
Patients that become severely immunocompromised because of 
underlying diseases such as leukemia, acquired 
immunodeficiency syndrome or patients who undergo cancer 
therapy, organ transplantation are particularly susceptible to 
opportunistic fungal infections [3]. A number of antifungal agents 
are available for the treatment of candidal infection [4].  
Recent studies have indicated C. albicans resitance to azoles or 
hepatotoxicity and nephrotoxicity linked to polyene use, 
particularly amphotericin B [5].  
The search for new molecular targets for antifungals has 
generated considerable research. Na, K-ATPase and H, K-
ATPase are well established molecular targets for several 
clinically important therapeutics [6,7]. Fungal plasma membrane 
H+ ATPase has well defined properties that make it a highly 
desirable target. It plays a critical role in fungal physiology. It is 
essential for generating and maintaining an electrochemical 
gradient that is required for nutrient uptake. PM-ATPase is also 
associated with regulation of intracellular pH, dimorphism and 
pathogenicity of the fungus [8]. Several reports suggest H+ 
ATPase to be a desirable antifungal target [9-13]. 
  Spices and herbs have now long been recognized for 
their medicinal values. Essential oils have been used as home 
remedies for the treatment of vaginal candidiasis [14]. Eugenol, a 
phenolic compound is the main component of clove (Eugenia 
caryophillis) oil the compound are present in essential oils of 
many plants and are proved to be active against many pathogenic 
bacteria, fungi and viruses [15]. There is a dearth of information 
on the effects of these bioactive compounds on C. albicans.  
Also there are no reports of using these compounds as inhibitory 
agents against PM-ATPase of C. albicans. Therefore, the present 
study was undertaken to evaluate the efficacy of eugenol as anti-
Candidal agent targeting its plasma membrane ATPase. 
Conclusion 
Eugenol has inhibitory effects on growth and H+-Extrusion of H+ 
ATPase of C. albicans. Both glucose and xylose along with 
Eugenol have inhibitory effect on Candida growth but no such 
effect has been observed on H+-ATPase pump of the fungus. 
Therefore Eugenol is a potential candidate to be exploited as 
future antifungal drug to target plasma membrane H+ ATPase of 
C. albicans and other pathogenic microbes. 
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Table.1- Effect of Eugenol on H+ efflux of C. albicans 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time control 500ug/ml 625ug/ml 1000ug/ml 2000ug/ml 
0 7 7 7 7 7 
1 6.76 6.67 6.73 6.93 6.96 
2 6.74 6.57 6.63 6.89 6.92 
3 6.57 6.5 6.57 6.87 6.87 
4 6.51 6.46 6.52 6.85 6.83 
5 6.46 6.42 6.48 6.81 6.79 
6 6.43 6.38 6.45 6.78 6.75 
7 6.4 6.37 6.42 6.75 6.72 
8 6.38 6.34 6.4 6.71 6.7 
9 6.37 6.33 6.38 6.68 6.69 
10 6.36 6.31 6.37 6.66 6.68 
11 6.34 6.29 6.37 6.65 6.68 
12 6.33 6.27 6.36 6.65 6.68 
13 6.32 6.26 6.34 6.65 6.68 
14 6.31 6.26 6.33 6.66 6.68 
15 6.31 6.26 6.32 6.67 6.69 
16 6.31 6.26 6.32 6.68 6.7 
17 6.3 6.27 6.32 6.69 6.71 
18 6.29 6.27 6.32 6.7 6.72 
19 6.27 6.28 6.33 6.71 6.73 
20 6.26 6.29 6.33 6.71 6.73 
21 6.25 6.3 6.33 6.72 6.74 
22 6.24 6.3 6.33 6.72 6.75 
23 6.24 6.3 6.34 6.73 6.76 
24 6.23 6.3 6.35 6.74 6.77 
25 6.22 6.31 6.35 6.75 6.77 
26 6.21 6.32 6.36 6.76 6.78 
27 6.21 6.33 6.37 6.76 6.79 
28 6.2 6.34 6.38 6.77 6.8 
29 6.2 6.35 6.39 6.77 6.81 
30 6.19 6.36 6.4 6.77 6.82 
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Table.2- Effect of Eugenol + glucose on H+ efflux of C. albicans 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time control 500ug/ml 625ug/ml 1000ug/ml 2000ug/ml 
0 7 7 7 7 7 
1 6.76 6.72 6.88 6.89 6.9 
2 6.74 6.56 6.77 6.78 6.81 
3 6.57 6.46 6.69 6.71 6.74 
4 6.51 6.37 6.62 6.67 6.69 
5 6.46 6.32 6.56 6.59 6.68 
6 6.43 6.28 6.52 6.57 6.63 
7 6.4 6.24 6.49 6.55 6.59 
8 6.38 6.19 6.44 6.49 6.57 
9 6.37 6.17 6.41 6.48 6.53 
10 6.36 6.17 6.4 6.47 6.51 
11 6.34 6.18 6.38 6.47 6.54 
12 6.33 6.18 6.39 6.46 6.54 
13 6.32 6.18 6.4 6.46 6.55 
14 6.31 6.19 6.4 6.46 6.56 
15 6.31 6.19 6.4 6.47 6.57 
16 6.31 6.19 6.4 6.47 6.58 
17 6.3 6.2 6.41 6.48 6.6 
18 6.29 6.21 6.42 6.49 6.61 
19 6.27 6.24 6.43 6.49 6.62 
20 6.26 6.25 6.43 6.5 6.64 
21 6.25 6.25 6.44 6.51 6.65 
22 6.24 6.26 6.45 6.52 6.67 
23 6.24 6.27 6.47 6.53 6.68 
24 6.23 6.28 6.5 6.53 6.69 
25 6.22 6.31 6.52 6.55 6.7 
26 6.21 6.33 6.54 6.56 6.72 
27 6.21 6.36 6.56 6.58 6.73 
28 6.2 6.37 6.56 6.6 6.75 
29 6.2 6.39 6.57 6.62 6.76 
30 6.19 6.4 6.6 6.63 6.79 
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Table.3- Effect of Eugenol + xylose on H+ efflux of C. albicans 
 
Time Control 500µg/ml 625µg/ml 1000µg/ml 2000µg/ml 
0 7 7 7 7 7 
1 6.71 6.77 6.73 6.89 6.9 
2 6.6 6.65 6.63 6.78 6.83 
3 6.53 6.56 6.57 6.71 6.79 
4 6.43 6.49 6.52 6.67 6.74 
5 6.39 6.44 6.48 6.59 6.7 
6 6.34 6.4 6.45 6.57 6.67 
7 6.32 6.37 6.44 6.55 6.64 
8 6.3 6.35 6.42 6.53 6.62 
9 6.28 6.32 6.4 6.49 6.6 
10 6.27 6.3 6.39 6.47 6.59 
11 6.26 6.28 6.37 6.47 6.58 
12 6.25 6.26 6.36 6.47 6.57 
13 6.24 6.24 6.34 6.46 6.56 
14 6.23 6.23 6.33 6.46 6.54 
15 6.23 6.21 6.32 6.47 6.54 
16 6.22 6.2 6.32 6.47 6.56 
17 6.21 6.19 6.32 6.47 6.56 
18 6.21 6.19 6.32 6.47 6.56 
19 6.21 6.2 6.32 6.48 6.56 
20 6.2 6.21 6.32 6.49 6.57 
21 6.19 6.2 6.33 6.51 6.58 
22 6.18 6.19 6.33 6.52 6.59 
23 6.18 6.19 6.34 6.53 6.62 
24 6.18 6.18 6.34 6.54 6.63 
25 6.18 6.18 6.34 6.55 6.64 
26 6.17 6.18 6.35 6.56 6.65 
27 6.16 6.19 6.37 6.56 6.66 
28 6.16 6.19 6.37 6.57 6.66 
29 6.15 6.2 6.39 6.59 6.67 
30 6.14 6.2 6.39 6.6 6.67 
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Figure.1- Effect of Eugenol on H+ efflux of C. albicans 
 
 
 
 
 
 
 Figure.2- Effect of Eugenol + glucose on H+ efflux of C. albicans 
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Figure.3- Effect of Eugenol + xylose on H+ efflux of C. albicans 
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